Steve Lockton

Title: Innovations of Steve Lockton

Introduction

Steve Lockton is an accomplished inventor based in San Diego, CA (US). He has made significant contributions to the field of personalized therapy management, holding a total of 3 patents. His work focuses on optimizing therapeutic approaches to improve patient outcomes.

Latest Patents

One of Steve Lockton's latest patents is titled "Methods of disease activity profiling for personalized therapy management." This invention provides methods for personalized therapeutic management of a disease to optimize therapy and monitor therapeutic efficacy. The invention involves measuring an array of one or multiple biomarkers at various time points during therapy with a therapeutic agent. This process helps determine a mucosal healing index for selecting therapy, optimizing treatment, reducing toxicity, and monitoring the efficacy of therapeutic interventions. In certain cases, the therapeutic agent is a TNFα inhibitor used for treating TNFα-mediated diseases or disorders.

Career Highlights

Throughout his career, Steve Lockton has worked with notable companies such as Prometheus Laboratories Inc. and Nestec S.A. His experience in these organizations has contributed to his expertise in the field of therapeutic management and innovation.

Collaborations

Steve has collaborated with professionals like Sharat Singh and Nicholas Hoe, enhancing his work through shared knowledge and expertise.

Conclusion

Steve Lockton's innovative contributions to personalized therapy management demonstrate his commitment to improving healthcare outcomes. His patents reflect a deep understanding of disease management and therapeutic optimization.